Published in Gut on March 01, 2001
Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut (2004) 1.92
Gastro-oesophageal reflux disease. BMJ (2006) 1.81
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus. World J Gastroenterol (2011) 0.92
Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma. Dig Dis Sci (2006) 0.80
Fundoplication for gastroesophageal reflux and factors associated with the outcome 6 to 10 years after the operation: multivariate analysis of prognostic factors using the propensity score. Surg Endosc (2008) 0.78
MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux. BMC Res Notes (2011) 0.78
Hiatal hernia, Barrett's esophagus, and long-term symptom control after laparoscopic fundoplication for gastroesophageal reflux. Surg Endosc (2012) 0.77
Advancements in the analysis of esophageal pH monitoring in GERD. Nat Rev Gastroenterol Hepatol (2011) 0.77
Laparoscopic treatment of Barrett's esophagus: long-term results. Surg Endosc (2006) 0.77
A case of Barrett's oesophagus in pernicious anaemia: acid is not the only culprit! Therap Adv Gastroenterol (2016) 0.77
Correlation of the location of superficial Barrett's esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux. Endosc Int Open (2016) 0.76
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus. Am J Gastroenterol (2015) 0.75
Extensive telomere erosion is consistent with localised clonal expansions in Barrett's metaplasia. PLoS One (2017) 0.75
Barrett's esophagus--Who, how, how often and what to do with dysplasia? Can J Gastroenterol (2006) 0.75
Ambulatory pH Monitoring: New Advances and Indications. Gastroenterol Hepatol (N Y) (2006) 0.75
Oesophageal pH monitoring in Barrett's oesophagus. Gut (2003) 0.75
The effect of laparoscopic fundoplication in therapy of Barrett's esophagus. Wideochir Inne Tech Maloinwazyjne (2014) 0.75
Differences in the Characteristics of Barrett's Esophagus and Barrett's Adenocarcinoma between the United States and Japan. ISRN Gastroenterol (2013) 0.75
The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus. Dig Dis Sci (2013) 0.75
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1998) 4.68
Patterns of gastroesophageal reflux in health and disease. Ann Surg (1976) 4.07
Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology (1994) 3.89
Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology (1992) 3.86
Barrett's esophagus. N Engl J Med (1986) 3.62
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology (1999) 2.47
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology (1999) 2.46
Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology (1996) 2.44
The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol (1997) 2.03
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci (1988) 1.91
Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest (1996) 1.81
Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol (1994) 1.67
Effect of bile salts and related compounds on isolated esophageal mucosa. Surgery (1980) 1.46
Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. Gastrointest Endosc (1996) 1.30
The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg (1999) 1.29
Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus. Am J Gastroenterol (1998) 1.02
Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus. Aliment Pharmacol Ther (1998) 1.02
Surgical management of Barrett's esophagus. Ann Chir Gynaecol (1995) 0.81
Accurate placement of the esophageal pH electrode for 24-hour pH monitoring using a combined pH/manometry probe. Am J Gastroenterol (2000) 0.81
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med (2000) 4.08
Identification of genes that modify ataxin-1-induced neurodegeneration. Nature (2000) 4.02
Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med (1993) 3.62
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 3.60
The NIMH community violence project: I. Children as victims of and witnesses to violence. Psychiatry (1993) 2.96
Are endoscopic measurements of colonic polyps reliable? Am J Gastroenterol (1993) 2.64
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol (1997) 2.43
The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc (1991) 2.17
Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med (1970) 2.16
Colon cancer reduction. Questions about implementation of proven techniques. Arch Intern Med (1997) 2.12
Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11
Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling. Am J Clin Pathol (1990) 2.10
Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax (2008) 2.02
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci (1999) 1.98
Prevalence of Leishmania infection among AIDS patients. Lancet (1992) 1.93
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol (1997) 1.81
Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut (2003) 1.81
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol (2012) 1.80
Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J Clin Invest (1981) 1.79
Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol (1998) 1.77
Endosymbiotic origin and codon bias of the nuclear gene for chloroplast glyceraldehyde-3-phosphate dehydrogenase from maize. J Mol Evol (1987) 1.77
Non-erosive reflux disease (NERD)--acid reflux and symptom patterns. Aliment Pharmacol Ther (2003) 1.69
Hepatitis C: and miles to go before we sleep. N Engl J Med (1989) 1.67
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol (2000) 1.63
Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis (1998) 1.61
Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology (1989) 1.61
NSAID effect on sporadic colon polyps. Am J Gastroenterol (1993) 1.60
Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis (1982) 1.59
Flow cytometry in Barrett's esophagus. What have we learned so far? Dig Dis Sci (1991) 1.48
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut (2000) 1.46
Intestinal metaplasia of the gastric cardia. Am J Gastroenterol (1997) 1.45
Effectiveness of India ink as a long-term colonic mucosal marker. Am J Gastroenterol (1992) 1.45
Limitations of combined flexible sigmoidoscopy and double contrast barium enema in patients with rectal bleeding. Eur J Radiol (1989) 1.42
Antioxidants and the prevention of coronary heart disease. Arch Intern Med (1995) 1.41
A procedure for the estimation of microgram quantities of triton X-100. Anal Biochem (1973) 1.40
The difference in colon polyp size before and after removal. Gastrointest Endosc (1996) 1.40
Intestinal metaplasia of the stomach: identification by a selective mucosal staining technique. Gastrointest Endosc (1993) 1.26
A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res (1999) 1.24
High protein ascites in patients with uncomplicated hepatic cirrhosis. Am J Med Sci (1974) 1.23
Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology (1994) 1.22
Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM). Lung Cancer (2012) 1.22
Triton X-100-4 M urea as an extraction medium for membrane proteins. I. Purification of chloroplast cytochrome b559. Biochemistry (1974) 1.20
Defective ADP-induced platelet factor 3 activation in uremia. Blood (1967) 1.19
Severe pulmonary hypertension in a patient with Whipple's disease. Am J Med (1985) 1.17
Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc (1996) 1.16
Caring behavior in children of clinically depressed and well mothers. Child Dev (1994) 1.14
Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med (1999) 1.13
ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. J Natl Cancer Inst (1986) 1.13
Young children of affectively ill parents: a longitudinal study of psychosocial development. J Am Acad Child Adolesc Psychiatry (1992) 1.13
Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci (1997) 1.13
Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol (1995) 1.12
Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci (1990) 1.12
Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol (2000) 1.11
Reaction to hepatitis B virus vaccine. Ann Intern Med (1984) 1.11
Laser therapy of Barrett's mucosa. Gastrointest Endosc (1993) 1.11
A sea urchin genome project: sequence scan, virtual map, and additional resources. Proc Natl Acad Sci U S A (2000) 1.10
The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther (2000) 1.10
Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci (1993) 1.08
Expression of the Hox gene complex in the indirect development of a sea urchin. Proc Natl Acad Sci U S A (1998) 1.05
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg (1996) 1.05
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study. Aliment Pharmacol Ther (2000) 1.04
Lack of spontaneous regression of tubular adenomas in two years of follow-up. Am J Gastroenterol (1997) 1.03
Orientation of the body response to galvanic stimulation as a function of the inter-vestibular imbalance. Exp Brain Res (2000) 1.02
Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol (1998) 1.01
Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J Biol Chem (2001) 1.00
Complexity and organization of DNA-protein interactions in the 5'-regulatory region of an endoderm-specific marker gene in the sea urchin embryo. Mech Dev (1994) 1.00
The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. Aliment Pharmacol Ther (2004) 1.00
P53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol (1992) 1.00
The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci (1979) 0.99
Colorectal neoplasms and Barrett's esophagus. Am J Gastroenterol (1986) 0.99
The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians. Arch Intern Med (2001) 0.99
Intrapericardial haematic cyst. A rare form of left superior vena cava atresia. Br Heart J (1984) 0.99
Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: effect on defibrillation success. Resuscitation (1990) 0.99
Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev (1993) 0.98
Sex peptide of Drosophila melanogaster males is a global regulator of reproductive processes in females. Proc Biol Sci (2012) 0.98
Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. Eur J Cancer (2001) 0.98
The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood (1993) 0.97
Barrett's esophagus: update on screening, surveillance, and treatment. Arch Intern Med (1999) 0.97
Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature. Neurosurgery (1986) 0.96
Hereditary hemorrhagic telangiectasia in three black men. Am J Gastroenterol (1978) 0.96